The schizophrenia drug Emraclidine failed to perform in clinical trials but executives say it can still “play a role.” ...
AbbVie has broken ground on a new $223 million expansion of its biologics manufacturing facility in Singapore, creating around 100 new jobs. The new investment will grow its workforce at the site ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback